Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-25 @ 3:28 AM
NCT ID:
NCT00692705
Eligibility Criteria:
Inclusion Criteria:
* Alzheimer´s Disease patients - 50-85 years- mild to moderate AD, clinical progression of AD over 12 months.
* Healthy male volunteers: - Age 20-50 years, Body Mass Index: 18-30 kg/m2.
* Clinically normal physical findings including normal blood pressure and pulse rate.
Exclusion Criteria:
* Alzheimer´s Disease patients:
* significant cerebrovascular disease or depression, central nervous system infarct or infection or lesions
* clinically significant illness within 2 weeks before the study start.
* administration of any investigational product with effect on brain beta amyloid levels within 3 months prior to study and/or participation in a PET investigation other than study D0180C00011 as part of a scientific study during the past 12 months,.
* Healthy volunteers; - clinically significant illness within 2 weeks before the study start, history of psychiatric or somatic disease/condition that may interfere.- first degree relative with dementia. Obvious deterioration of memory functions.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
85 Years
Study:
NCT00692705
Study Brief:
Protocol Section:
NCT00692705